Interleukin-6 inhibitors in the treatment of rheumatoid arthritis

by Stephanie Hennigan, Arthur Kavanaugh
Published 2008-09-01

Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic t...

by Arthur Kavanaugh, Glenn Haugeberg, Brigitte Michelsen
Published 2020-05-01

Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates

by Glenn Haugeberg, Mari Hoff, Arthur Kavanaugh, Brigitte Michelsen
Published 2020-08-01

The role of monoclonal antibodies in the treatment of severe asthma

by Louanne M. Tourangeau, Arthur Kavanaugh, Stephen I. Wasserman
Published 2011-06-01

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout

by Leonard H. Calabrese, Arthur Kavanaugh, Anthony E. Yeo, Peter E. Lipsky
Published 2017-08-01

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research

by Désirée van der Heijde, Dafna D. Gladman, Arthur Kavanaugh, Philip J. Mease
Published 2020-02-01

Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care.

by Brigitte Michelsen, Kristine Thomassen Berget, Jon Håvard Loge, Arthur Kavanaugh, Glenn Haugeberg
Published 2022-01-01

Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

by Glenn Haugeberg, Brigitte Michelsen, Stig Tengesdal, Inger Johanne Widding Hansen, Andreas Diamantopoulos, Arthur Kavanaugh
Published 2018-08-01

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

by Mark Genovese, Rene Westhovens, Luc Meuleners, Annegret Van der Aa, Pille Harrison, Chantal Tasset, Arthur Kavanaugh
Published 2018-03-01

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, r...

by Arthur Kavanaugh, Philip S Helliwell, Kristen Sweet, Yin You, Soumya D Chakravarty, Shelly Kafka, Chetan S Karyekar, Kim Campbell
Published 2020-05-01

Differences in oxylipin profile in psoriasis versus psoriatic arthritis

by Roxana Coras, Arthur Kavanaugh, Angela Kluzniak, Dustina Holt, Amy Weilgosz, Armando Aaron, Oswald Quehenberger, Christopher Ritchlin, Monica Guma
Published 2021-07-01

Changes of inflammation in patients with psoriatic arthritis after high intensity interval training assessed by ultrasound and MRI, a randomized controlled trial

by Ruth Stoklund Thomsen, Tom Ivar Lund Nilsen, Glenn Haugeberg, Beathe Sitter, Arthur Kavanaugh, Susanne Juhl Pedersen, Mari Hoff
Published 2023-09-01

Lipidomic Profiling in Synovial Tissue

by Roxana Coras, Roxana Coras, Jessica D. Murillo-Saich, Abha G. Singh, Arthur Kavanaugh, Monica Guma, Monica Guma, Monica Guma
Published 2022-04-01

A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

by Brigitte Michelsen, Ragnhild Fiane, Andreas P Diamantopoulos, Dag Magnar Soldal, Inger Johanne W Hansen, Tuulikki Sokka, Arthur Kavanaugh, Glenn Haugeberg
Published 2015-01-01

Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloa...

by Philip J. Mease, Soumya D. Chakravarty, Robert R. McLean, Taylor Blachley, Toana Kawashima, Iris Lin, Arthur Kavanaugh, Alexis Ogdie
Published 2022-05-01

Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis

by Rekha Narasimhan, Roxana Coras, Sara B. Rosenthal, Shannon R. Sweeney, Alessia Lodi, Stefano Tiziani, David Boyle, Arthur Kavanaugh, Monica Guma
Published 2018-08-01

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis

by Arthur Kavanaugh, Dafna D. Gladman, Christopher J. Edwards, Georg Schett, Benoit Guerette, Nikolay Delev, Lichen Teng, Maria Paris, Philip J. Mease
Published 2019-05-01

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

by Stéphane Paul, Hubert Marotte, Arthur Kavanaugh, Philippe Goupille, Tore K. Kvien, Marc deLongueville, Denis Mulleman, William J. Sandborn, Niels Vande Casteele
Published 2020-07-01

Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheuma...

by Janusz Jaworski, Marco Matucci-Cerinic, Hendrik Schulze-Koops, Maya H. Buch, Eugeniusz J. Kucharz, Yannick Allanore, Arthur Kavanaugh, Philip Young, Goran Babic
Published 2019-05-01

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study...

by Philip Mease, M. Elaine Husni, Soumya D. Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh
Published 2020-11-01